AUS
NZ
UK
CA
USA
IND
Cannabis
Cannabis Stocks on ASX 200: What’s Driving Attention?
June 03, 2026 11:29 AM AEST| By SamAustralia's medicinal cannabis industry continues expanding through patient access, healthcare adoption, manufacturing development, and export activity, with several ASX-listed companies shaping the sector.
Cannabis Stocks Across ASX 300 Gain Industry Attention
June 02, 2026 12:14 PM AEST| By SamAustralia's medicinal cannabis sector has evolved into a structured healthcare industry supported by patient access, manufacturing capability, distribution networks, and specialised product development.
Why Are ASX Cannabis Stocks Drawing Fresh Attention?
June 02, 2026 12:14 PM AEST| By SamExplore ASX cannabis stocks including Althea Group Holdings, Cann Group, Little Green Pharma, Incannex Healthcare, and Bod Science across healthcare and wellness markets.
Cannabis Stocks in All Ordinaries Market Spotlight
June 02, 2026 12:14 PM AEST| By SamAustralia's medicinal cannabis industry continues to evolve through healthcare innovation, regulation, manufacturing capability, patient access expansion, and international market participation.
Why Are Cannabis Stocks Drawing Global Market Interest?
June 01, 2026 10:45 AM AEST| By SamCannabis-focused companies remain a notable part of Australia's healthcare sector, with medicinal cannabis, pharmaceutical research, cultivation, and wellness products shaping industry activity in 2026.
Why Are Cannabis Stocks Back on the ASX 300 Radar?
June 01, 2026 10:44 AM AEST| By SamASX medicinal cannabis stocks remain in focus as patient access, regulation, product quality, exports, and healthcare distribution shape the sector in 2026.
Leading Cannabis Stocks Across ASX 200 Healthcare Focus
June 01, 2026 10:42 AM AEST| By SamExplore ASX cannabis stocks including Althea Group Holdings, Cann Group, Creso Pharma, Little Green Pharma, Bod Science, MGC Pharmaceuticals, and EcoFibre as medicinal cannabis continues evolving within Australia's healthcare sector.
Healthcare Innovators Across ASX 300 Remain in Focus
May 29, 2026 01:32 PM AEST| By SamEmerging healthcare companies continue participating in therapeutic research, healthcare technology development and patient-focused service activities across evolving healthcare markets.
Why Are ASX 300 Cannabis Healthcare Stocks Gaining Attention?
May 29, 2026 01:28 PM AEST| By SamIncannex Healthcare (ASX:IHL), Emyria (ASX:EMD) and Bod Science (ASX:BOD) represent specialised cannabis-healthcare businesses spanning therapeutic research, healthcare services and consumer wellness products.
ASX 300 Medicinal Cannabis Market Expands
May 29, 2026 01:25 PM AEST| By SamASX cannabis stocks LGP, CAN, and AGH highlight cultivation, production, and distribution within a regulated medicinal market shaped by healthcare adoption and evolving policies.
Cannabis Stocks Momentum Builds Across ASX 200
May 28, 2026 11:57 AM AEST| By SamCannabis Stocks on the ASX continue attracting attention as consolidation activity, benchmark participation, healthcare developments, and operational restructuring shape the evolving sector landscape.
Cannabis Stocks and ASX 300 Focus on Pharmacy Channels
May 28, 2026 11:57 AM AEST| By SamCannabis Stocks on the ASX remain linked with pharmacy participation, export frameworks, and healthcare distribution systems as sector attention continues across emerging medicinal cannabis operations and European commercial activity.
ASX Cannabis Stocks Active Across ASX 300 Discussions
May 28, 2026 11:50 AM AEST| By SamASX cannabis stocks remain active within Australia’s healthcare market as medicinal cannabis prescription activity and regulatory developments continue shaping sector discussions.
Noxopharm Gains Spotlight as Cancer Research Advances
May 27, 2026 07:38 PM AEST| By SamNoxopharm’s latest Sofra platform findings have renewed attention on cancer immunotherapy innovation as the biotech sector continues exploring advanced immune activation strategies for oncology treatment development.
ASX Cannabis Stock Risks: Key Traps to Watch
May 27, 2026 05:01 PM AEST| By SamASX cannabis stocks carry risks from volatility, regulation, funding needs, commercial adoption challenges, and execution pressure across Australia’s developing medicinal cannabis sector.
What’s Fueling Fresh Buzz Around ASX Cannabis Stocks?
May 27, 2026 04:27 PM AEST| By SamASX cannabis stocks continue evolving within Australia’s regulated medicinal cannabis market, with commercial adoption, operational execution, funding pressure, and healthcare-focused research shaping the sector’s outlook.
ASX Cannabis Stocks: What Smart Investors Are Watching
May 27, 2026 04:22 PM AEST| By SamASX cannabis stocks are increasingly assessed through commercial strength, operational execution, product economics and regulatory positioning as Australia’s medicinal cannabis industry continues maturing.
Cannabis Investment Risks: A Practical Guide for ASX Investors
May 26, 2026 03:03 PM AEST| By SamCannabis investing involves regulatory, commercial, and execution risks that Australian investors must manage thoughtfully through diversification, position sizing, and engagement with developments.
Evaluating Cannabis Companies: Beyond the Regulatory Headlines
May 26, 2026 02:57 PM AEST| By SamEvaluating cannabis businesses requires looking beyond regulatory headlines to examine commercial fundamentals, operational execution, and the specific economics of products in regulated markets.
Cannabis Stocks on the ASX: A Guide for Australian Investors
May 26, 2026 02:54 PM AEST| By SamHighlights,Cannabis stocks span medicinal, recreational, and adjacent businesses across different stages of regulatory and operational maturity.,Australian cannabis listings primarily focus on medicinal cannabis due to the local regulatory framework,...
Advertise your brand on Kalkine Media